Advertisement

Questions Remain About Verdict In New England Compounding Center Case08:13
Download

Play
A vial of injectable steroids from the New England Compounding Center is displayed in this 2012 file photo. (Kristin M. Hal/AP)
A vial of injectable steroids from the New England Compounding Center is displayed in this 2012 file photo. (Kristin M. Hal/AP)
This article is more than 3 years old.

As a federal judge prepares to sentence Barry Cadden, questions remain about the verdict. Cadden was the co-owner and lead pharmacist of the New England Compounding Center in Framingham.

Cadden was found guilty of racketeering and mail fraud after a fungal meningitis outbreak led to 64 deaths. Nearly 700 others became ill after being administered contaminated drugs that were mixed at the Framingham facility. Cadden was acquitted of second degree murder, which carried a maximum penalty of life in prison.

Guest

David Boeri, WBUR senior reporter. He tweets @davidboeri.

This segment aired on June 26, 2017.

Related:

Advertisement

Advertisement